{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:57:34Z","timestamp":1790222254298,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201180"],"award-info":[{"award-number":["82201180"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Clinical Projects of Peking University Third Hospital","award":["BYSY2022060"],"award-info":[{"award-number":["BYSY2022060"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00259-024-07015-y","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T06:45:28Z","timestamp":1734072328000},"page":"1890-1900","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of fibroinflammatory activity in thyroid eye disease using [18F]AlF-NOTA-FAPI-04 PET\/CT: A prospective study"],"prefix":"10.1007","volume":"52","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debo","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4196-8224","authenticated-orcid":false,"given":"Lingge","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"7015_CR1","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS. Graves\u2019 ophthalmopathy. N Engl J Med. 2010;362:726\u201338. https:\/\/doi.org\/10.1056\/NEJMra0905750.","journal-title":"N Engl J Med"},{"key":"7015_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b560","volume":"338","author":"P Perros","year":"2009","unstructured":"Perros P, Neoh C, Dickinson J. Thyroid eye disease. Bmj. 2009;338: b560. https:\/\/doi.org\/10.1136\/bmj.b560.","journal-title":"Bmj"},{"key":"7015_CR3","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/joim.13524","volume":"292","author":"L Bartalena","year":"2022","unstructured":"Bartalena L, Tanda ML. Current concepts regarding Graves\u2019 orbitopathy. J Intern Med. 2022;292:692\u2013716. https:\/\/doi.org\/10.1111\/joim.13524.","journal-title":"J Intern Med"},{"key":"7015_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/bjo.73.8.639","volume":"73","author":"MP Mourits","year":"1989","unstructured":"Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R. Clinical criteria for the assessment of disease activity in Graves\u2019 ophthalmopathy: a novel approach. Br J Ophthalmol. 1989;73:639\u201344. https:\/\/doi.org\/10.1136\/bjo.73.8.639.","journal-title":"Br J Ophthalmol"},{"key":"7015_CR5","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/eje-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C, et al. The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur J Endocrinol. 2021;185:G43-g67. https:\/\/doi.org\/10.1530\/eje-21-0479.","journal-title":"Eur J Endocrinol"},{"key":"7015_CR6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1507\/endocrj.EJ16-0165","volume":"63","author":"JW Kim","year":"2016","unstructured":"Kim JW, Woo YJ, Yoon JS. Is modified clinical activity score an accurate indicator of diplopia progression in Graves\u2019 orbitopathy patients? Endocr J. 2016;63:1133\u201340. https:\/\/doi.org\/10.1507\/endocrj.EJ16-0165.","journal-title":"Endocr J"},{"key":"7015_CR7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1507\/endocrj.k10e-156","volume":"57","author":"S Tachibana","year":"2010","unstructured":"Tachibana S, Murakami T, Noguchi H, Noguchi Y, Nakashima A, Ohyabu Y, et al. Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves\u2019 ophthalmopathy. Endocr J. 2010;57:853\u201361. https:\/\/doi.org\/10.1507\/endocrj.k10e-156.","journal-title":"Endocr J"},{"key":"7015_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/00006231-200505000-00003","volume":"26","author":"L Galuska","year":"2005","unstructured":"Galuska L, Leovey A, Szucs-Farkas Z, Szabados L, Garai I, Berta A, et al. Imaging of disease activity in Graves\u2019 orbitopathy with different methods: comparison of (99m)Tc-DTPA and (99m)Tc-depreotide single photon emission tomography, magnetic resonance imaging and clinical activity scores. Nucl Med Commun. 2005;26:407\u201314. https:\/\/doi.org\/10.1097\/00006231-200505000-00003.","journal-title":"Nucl Med Commun"},{"key":"7015_CR9","unstructured":"Galuska L, Nagy E, Sz\u00facs-Farkas Z, Szabados L, Garai I, Szab\u00f3 J, et al. [Assessment of autoimmune disease activity in endocrine orbitopathy: comparison of SPECT using 99m-Tc-DTPA or 99m-Tc-depreotide and MRI scores]. Orv Hetil. 2003;144:2017\u201322."},{"key":"7015_CR10","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1007\/s00259-023-06312-2","volume":"50","author":"N Yao","year":"2023","unstructured":"Yao N, Li L, Gao Z, Zhao C, Li Y, Han C, et al. Deep learning-based diagnosis of disease activity in patients with Graves\u2019 orbitopathy using orbital SPECT\/CT. Eur J Nucl Med Mol Imaging. 2023;50:3666\u201374. https:\/\/doi.org\/10.1007\/s00259-023-06312-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7015_CR11","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1007\/s00259-021-05343-x","volume":"48","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Yang X, Liu H, Luo W, Liu H, Lv T, et al. Value of [(68)Ga]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis. Eur J Nucl Med Mol Imaging. 2021;48:3493\u2013501. https:\/\/doi.org\/10.1007\/s00259-021-05343-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7015_CR12","doi-asserted-by":"publisher","first-page":"e222389","DOI":"10.1148\/radiol.222389","volume":"307","author":"M Scharitzer","year":"2023","unstructured":"Scharitzer M, Macher-Beer A, Mang T, Unger LW, Haug A, Reinisch W, et al. Evaluation of Intestinal Fibrosis with (68)Ga-FAPI PET\/MR Enterography in Crohn Disease. Radiology. 2023;307:e222389. https:\/\/doi.org\/10.1148\/radiol.222389.","journal-title":"Radiology"},{"key":"7015_CR13","doi-asserted-by":"publisher","first-page":"e222052","DOI":"10.1148\/radiol.222052","volume":"307","author":"Y Luo","year":"2023","unstructured":"Luo Y, Pan Q, Zhou Z, Li M, Wei Y, Jiang X, et al. (68)Ga-FAPI PET\/CT for rheumatoid arthritis: A prospective study. Radiology. 2023;307:e222052. https:\/\/doi.org\/10.1148\/radiol.222052.","journal-title":"Radiology"},{"key":"7015_CR14","doi-asserted-by":"publisher","first-page":"e220749","DOI":"10.1148\/radiol.220749","volume":"306","author":"Y Mori","year":"2023","unstructured":"Mori Y, Dendl K, Cardinale J, Kratochwil C, Giesel FL, Haberkorn U. FAPI PET: Fibroblast activation protein inhibitor use in oncologic and nononcologic disease. Radiology. 2023;306:e220749. https:\/\/doi.org\/10.1148\/radiol.220749.","journal-title":"Radiology"},{"key":"7015_CR15","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.2967\/jnumed.122.263922","volume":"63","author":"T Kuwert","year":"2022","unstructured":"Kuwert T, Schmidkonz C, Prante O, Schett G, Ramming A. FAPI PET opens a new window to understanding immune-mediated inflammatory diseases. J Nucl Med. 2022;63:1136\u20137. https:\/\/doi.org\/10.2967\/jnumed.122.263922.","journal-title":"J Nucl Med"},{"key":"7015_CR16","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1089\/thy.2007.0404","volume":"18","author":"TJ Smith","year":"2008","unstructured":"Smith TJ, Tsai CC, Shih MJ, Tsui S, Chen B, Han R, et al. Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. Thyroid. 2008;18:983\u20138. https:\/\/doi.org\/10.1089\/thy.2007.0404.","journal-title":"Thyroid"},{"key":"7015_CR17","doi-asserted-by":"publisher","first-page":"101620","DOI":"10.1016\/j.beem.2022.101620","volume":"37","author":"ACH Lee","year":"2023","unstructured":"Lee ACH, Kahaly GJ. Pathophysiology of thyroid-associated orbitopathy. Best Pract Res Clin Endocrinol Metab. 2023;37:101620. https:\/\/doi.org\/10.1016\/j.beem.2022.101620.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"7015_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40618-021-01663-9","volume":"45","author":"EJ Neag","year":"2022","unstructured":"Neag EJ, Smith TJ. 2021 update on thyroid-associated ophthalmopathy. J Endocrinol Invest. 2022;45:235\u201359. https:\/\/doi.org\/10.1007\/s40618-021-01663-9.","journal-title":"J Endocrinol Invest"},{"key":"7015_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12020-021-02962-0","volume":"76","author":"Z Rao","year":"2022","unstructured":"Rao Z, Wu J, Zhang C. A case of papillary thyroid carcinoma with Graves ophthalmopathy evaluated by (68)Ga-FAPI PET\/CT. Endocrine. 2022;76:243\u20134. https:\/\/doi.org\/10.1007\/s12020-021-02962-0.","journal-title":"Endocrine"},{"key":"7015_CR20","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/rlu.0000000000003703","volume":"46","author":"H Liu","year":"2021","unstructured":"Liu H, Yang X, Wang Y, Wang P, Chen Y. 68Ga-FAPI PET\/CT imaging of graves ophthalmopathy in a patient with esophageal cancer. Clin Nucl Med. 2021;46:938\u20139. https:\/\/doi.org\/10.1097\/rlu.0000000000003703.","journal-title":"Clin Nucl Med"},{"key":"7015_CR21","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/s0161-6420(84)34152-5","volume":"91","author":"TJ Hufnagel","year":"1984","unstructured":"Hufnagel TJ, Hickey WF, Cobbs WH, Jakobiec FA, Iwamoto T, Eagle RC. Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves\u2019 disease. Ophthalmology. 1984;91:1411\u20139. https:\/\/doi.org\/10.1016\/s0161-6420(84)34152-5.","journal-title":"Ophthalmology"},{"key":"7015_CR22","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1089\/thy.2015.0087","volume":"25","author":"L Marique","year":"2015","unstructured":"Marique L, Senou M, Craps J, Delaigle A, Van Regemorter E, W\u00e9rion A, et al. Oxidative stress and upregulation of antioxidant proteins, including adiponectin, in extraocular muscular cells, orbital adipocytes, and thyrocytes in graves\u2019 disease associated with orbitopathy. Thyroid. 2015;25:1033\u201342. https:\/\/doi.org\/10.1089\/thy.2015.0087.","journal-title":"Thyroid"},{"key":"7015_CR23","first-page":"259","volume":"13","author":"S Li","year":"2023","unstructured":"Li S, Liu YJ. Application of quantitative orbital analysis to assess the activity of Graves\u2019 ophthalmopathy. Am J Nucl Med Mol Imaging. 2023;13:259\u201368.","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"7015_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3892\/etm.2016.3389","volume":"12","author":"H Hu","year":"2016","unstructured":"Hu H, Xu XQ, Wu FY, Chen HH, Su GY, Shen J, et al. Diagnosis and stage of Graves\u2019 ophthalmopathy: Efficacy of quantitative measurements of the lacrimal gland based on 3-T magnetic resonance imaging. Exp Ther Med. 2016;12:725\u20139. https:\/\/doi.org\/10.3892\/etm.2016.3389.","journal-title":"Exp Ther Med"},{"key":"7015_CR25","doi-asserted-by":"publisher","first-page":"e210590","DOI":"10.1530\/ec-21-0590","volume":"11","author":"RX Zhao","year":"2022","unstructured":"Zhao RX, Shi TT, Luo S, Liu YF, Xin Z, Yang JK. The value of SPECT\/CT imaging of lacrimal glands as a means of assessing the activity of Graves\u2019 orbitopathy. Endocr Connect. 2022;11:e210590. https:\/\/doi.org\/10.1530\/ec-21-0590.","journal-title":"Endocr Connect."}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-07015-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-024-07015-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-07015-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T19:52:56Z","timestamp":1742673176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-024-07015-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["7015"],"URL":"https:\/\/doi.org\/10.1007\/s00259-024-07015-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Peking University Third Hospital (M2023762 and M2024362).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent for publication was obtained from the individual participant for whom identifying information is included in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}